昱展新藥生技 ALAR PHARMACEUTICALS INC
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Alar Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000 2022-01-13 00:00
Breaking the Cycle of Opioid Addiction: Alar Presents Positive Interim Results of Long-acting Buprenorphine Injectable (ALA-1000) in Opioid Dependent Patients 2021-03-10 00:00
1